LIBERTY PARTNERS GROUP, LLC

Lobbying for TELIX PHARMACEUTICALS US · Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Indiana · House · Senate · $52,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Health Issues

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medicare/Medicaid

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Medical/Disease Research/Clinical Labs

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.